Cigna Group (CI) Expected to Release Earnings on Thursday

by · The Cerbat Gem

Cigna Group (NYSE:CI – Get Free Report) is expected to release its Q3 2026 results before the market opens on Thursday, November 5th. Analysts expect the company to announce earnings of $7.52 per share and revenue of $72.64 billion for the quarter. Individuals can check the company’s upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Thursday, November 5, 2026 at 8:30 AM ET.

Cigna Group Stock Performance

Cigna Group stock opened at $295.20 on Tuesday. The stock has a market cap of $78.00 billion, a P/E ratio of 9.37, a price-to-earnings-growth ratio of 1.00 and a beta of 0.29. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. The stock has a 50 day moving average of $284.24 and a 200-day moving average of $281.65. Cigna Group has a 52 week low of $239.51 and a 52 week high of $316.27.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 17th. Investors of record on Thursday, December 3rd will be paid a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date is Thursday, December 3rd. Cigna Group’s payout ratio is 25.82%.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the stock. Guggenheim upped their price target on shares of Cigna Group from $338.00 to $361.00 and gave the company a “buy” rating in a report on Friday, July 31st. Jefferies Financial Group lowered shares of Cigna Group from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $336.00 to $307.00 in a report on Tuesday, August 4th. Evercore initiated coverage on shares of Cigna Group in a research report on Wednesday, September 9th. They issued an “in-line” rating and a $290.00 target price for the company. Piper Sandler reissued an “overweight” rating on shares of Cigna Group in a research report on Friday, October 23rd. Finally, Royal Bank Of Canada restated an “outperform” rating and issued a $337.00 target price on shares of Cigna Group in a research note on Thursday, October 1st. Fifteen equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $338.24.

Get Our Latest Analysis on Cigna Group

Insider Activity at Cigna Group

In related news, insider Nicole S. Jones sold 2,677 shares of the company’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total transaction of $748,515.97. Following the sale, the insider directly owned 25,880 shares of the company’s stock, valued at approximately $7,236,306.80. This represents a 9.37% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the firm’s stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total value of $175,258.85. Following the transaction, the insider owned 5,053 shares in the company, valued at $1,435,304.65. This trade represents a 10.88% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by company insiders.

About Cigna Group

(Get Free Report)

The Cigna Group (NYSE: CI) is a global health services company that provides insurance coverage, health care benefits and related services. Its operations are primarily organized through Cigna Healthcare, which offers medical, pharmacy, dental, behavioral health and other benefit programs to employers, government organizations and individuals, primarily in the United States.

The company also operates Evernorth Health Services, a health services platform that includes pharmacy benefit management, specialty pharmacy, care management and health-care delivery capabilities.

Read More